Ping Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ping Wang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ding Ma
State Key Laboratory of Pharmaceutical Biotechnology, National Institute of Healthcare Data Science at Nanjing University, Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, Jiangsu, China
1 shared publication - Fujie Zhao
Department of Genecology and Obstetrics, Shengjing Hospital Affiliated with China Medical University, Shenyang 110004, China
1 shared publication - Hong Li
West China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, China
1 shared publication - Hongyan Guo
Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
1 shared publication - Hui Wang
Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China
1 shared publication - Jianliu Wang
Peking University People’s Hospital
1 shared publication
Latest Publications
- Open Access
- 1 February 2020
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 8 (4) , 79
Chinese expert consensus on the prevention of abdominal pelvic adhesions after gynecological tumor surgeries
Adhesion is a postoperative complication that has plagued gynecologists for many years, as 60–90% of gynecological patients develop adhesions after abdominopelvic surgeries. Abdominopelvic adhesions could lead to chronic pelvic pain, infertility, intestinal obstruction, and complicated reoperations. Adhesions might also increase the risk of postoperative chemoradiotherapy failure and endanger patients’ lives, especially after surgeries for gynecological malignant tumors. The aim of this consensus was to review the pathogenesis and clinical consequences of adhesions and to summarize various surgical procedures and preventive measures that can reduce the occurrence of adhesions after gynecological tumor surgeries based on a discussion among well-known domestic gynecology specialists.
- 1 February 2020
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 8 (4) , 79
Open AccessChinese expert consensus on the prevention of abdominal pelvic adhesions after gynecological tumor surgeries
Adhesion is a postoperative complication that has plagued gynecologists for many years, as 60–90% of gynecological patients develop adhesions after abdominopelvic surgeries. Abdominopelvic adhesions could lead to chronic pelvic pain, infertility, intestinal obstruction, and complicated reoperations. Adhesions might also increase the risk of postoperative chemoradiotherapy failure and endanger patients’ lives, especially after surgeries for gynecological malignant tumors. The aim of this consensus was to review the pathogenesis and clinical consequences of adhesions and to summarize various surgical procedures and preventive measures that can reduce the occurrence of adhesions after gynecological tumor surgeries based on a discussion among well-known domestic gynecology specialists.
- 10 October 2014
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (3) , 478-482
Ewing's sarcoma/peripheral primitive neuroectodermal tumors of the uterus confirmed with fluorescence in situ hybridization in a 29‐year‐old Chinese female: A case report and published work review
Ewing's sarcoma/peripheral primitive neuroectodermal tumors (ES/pPNET) are a group of small round cell sarcomas that show varying degrees of neuroectodermal differentiation characterized by translocation involving the EWS gene. Uterine ES/pPNET is a rare entity. A 29‐year‐old Chinese female who presented with abdominal swelling and pain was diagnosed with a primary uterine ES/pPNET on the basis of clinicopathologic, immunohistochemical and fluorescence in situ hybridization (FISH) data. She was given a multimodal treatment, including neoadjuvant, 95% cytoreductive, chemotherapy and radiotherapy. The patient is currently alive with persistent disease after 18 months of follow‐up. We emphasized the crucial role of molecular techniques in the differential diagnosis of small round cell tumors in this unusual location. Multimodal therapy may improve the outcomes of patients.
- 10 October 2014
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (3) , 478-482
Ewing's sarcoma/peripheral primitive neuroectodermal tumors of the uterus confirmed with fluorescence in situ hybridization in a 29‐year‐old Chinese female: A case report and published work review
Ewing's sarcoma/peripheral primitive neuroectodermal tumors (ES/pPNET) are a group of small round cell sarcomas that show varying degrees of neuroectodermal differentiation characterized by translocation involving the EWS gene. Uterine ES/pPNET is a rare entity. A 29‐year‐old Chinese female who presented with abdominal swelling and pain was diagnosed with a primary uterine ES/pPNET on the basis of clinicopathologic, immunohistochemical and fluorescence in situ hybridization (FISH) data. She was given a multimodal treatment, including neoadjuvant, 95% cytoreductive, chemotherapy and radiotherapy. The patient is currently alive with persistent disease after 18 months of follow‐up. We emphasized the crucial role of molecular techniques in the differential diagnosis of small round cell tumors in this unusual location. Multimodal therapy may improve the outcomes of patients.